Michael Straughen - Apr 1, 2022 Form 4 Insider Report for CORE LABORATORIES N V (CLB)

Role
Director
Signature
/s/ Mark Tattoli, Attorney-in-Fact
Stock symbol
CLB
Transactions as of
Apr 1, 2022
Transactions value $
-$64,276
Form type
4
Date filed
4/4/2022, 05:05 PM
Next filing
Apr 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLB Common Shares Tax liability -$64.3K -1.98K -12.8% $32.43* 13.5K Apr 1, 2022 Direct
transaction CLB Common Shares Options Exercise $0 +4.31K +38.52% $0.00 15.5K Apr 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Restricted Shares Award $0 +5.49K $0.00 5.49K Apr 1, 2022 Common Shares 5.49K $0.00 Direct F1
transaction CLB Restricted Shares Options Exercise $0 -4.31K -100% $0.00* 0 Apr 1, 2022 Common Shares 4.31K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2023, subject to the terms of issuance.
F2 The Restricted Shares vested at the end of a one-year vesting period on April 1, 2022.